.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
QuintilesIMS
Fuji
Moodys
Farmers Insurance
Cantor Fitzgerald
Covington
Deloitte
UBS
AstraZeneca

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087122

« Back to Dashboard

NDA 087122 describes METHDILAZINE HYDROCHLORIDE, which is a drug marketed by Alpharma Us Pharms and is included in one NDA. Additional details are available on the METHDILAZINE HYDROCHLORIDE profile page.

The generic ingredient in METHDILAZINE HYDROCHLORIDE is methdilazine hydrochloride. There are four drug master file entries for this compound. Additional details are available on the methdilazine hydrochloride profile page.

Summary for 087122

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SYRUP;ORALStrength4MG/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
Baxter
Chinese Patent Office
Farmers Insurance
Colorcon
Novartis
McKinsey
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot